Cite
HARVARD Citation
Cummings, J. et al. (n.d.). P3‐301: Dextromethorphan/quinidine (AVP‐923) phase 2 study for treatment of agitation in Alzheimer's disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440). Alzheimer's & dementia. p. P751. [Online].